Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias
批准号:
10209753
负责人:
DAVID EISENBERG
金额:
$156.98万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-01 至 2026-06-30
关键词:
AddressAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease related dementiaAmyloid beta-ProteinAntibodiesAppearanceAreaAtomic Force MicroscopyBiochemicalBiologicalBiological ModelsCentrifugationCharacteristicsChemicalsClinicalCommunitiesCryoelectron MicroscopyDetectionDiagnosisDiagnosticDiseaseDisease VectorsElectronsFilamentFluorescence MicroscopyGenetic PolymorphismGoalsHigh PrevalenceHigher Order Chromatin StructureHumanImmunologicsInterdisciplinary StudyLesionMass Spectrum AnalysisMeasurementMethodsMissionMolecularMorphologyNerve DegenerationNeurodegenerative DisordersPathogenesisPathologyPeptide HydrolasesPick Disease of the BrainPolymorphPost-Translational Protein ProcessingPreparationProgressive Supranuclear PalsyProteinsProteomicsProtocols documentationRadioReagentRecombinantsReproducibilityResearchResearch SupportResourcesRoleSamplingSeedsSeverity of illnessSourceSpecimenStagingStandardizationStructureSurrogate MarkersTauopathiesTissuesToxic effectValidationalpha synucleinanimal tissuebiophysical analysisbrain tissuecomorbiditycorticobasal degenerationdisease diagnosishuman diseasehuman tissueinnovationnovel diagnosticsnovel therapeutic interventionorganizational structureprotein TDP-43protein aggregationsynaptic functiontau Proteinstau aggregationtooltransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Tau aggregation is a shared pathology of Alzheimer's disease and related dementias known as tauopathies.
Because each disorder develops a unique combination of aggregate polymorphisms and co-morbidities that may
influence the course and severity of disease, elucidating the relationship between tau aggregate structure and
biological activity has become a high priority in the field. Advances to date have been limited, however, by the
lack of rigorously standardized aggregate preparations from each form of tauopathy and by the absence of tools
needed to selectively detect their presence in biological models and clinical specimens. The proposed
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs seeks to address this need
by (1) isolating a full range of biologically active tau aggregates from authentic Alzheimer's disease, Corticobasal
Degeneration, Progressive Supranuclear Palsy, and Pick's disease brain tissue, (2) establishing their structures
through biophysical analysis, (3) developing probe sets for their selective detection, and (4) disseminating
reliably vetted samples and lab-ready protocols for their handling and storage to the broader research
community. In accomplishing these goals, the network will support research into the molecular basis of tauopathy
pathogenesis and catalyze efforts toward creating novel diagnostic and therapeutic strategies specifically tailored
against toxic tau aggregate polymorphs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures
-
批准号:10370874
-
项目类别:
-
资助金额:$106.84万
-
财政年份:2022
-
负责人:DAVID EISENBERG
-
依托单位:
Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures
-
批准号:10544785
-
项目类别:
-
资助金额:$119.25万
-
财政年份:2022
-
负责人:DAVID EISENBERG
-
依托单位:
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias
-
批准号:10657390
-
项目类别:
-
资助金额:$155.45万
-
财政年份:2021
-
负责人:DAVID EISENBERG
-
依托单位:
Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures
-
批准号:10330046
-
项目类别:
-
资助金额:$107.56万
-
财政年份:2021
-
负责人:DAVID EISENBERG
-
依托单位:
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias
-
批准号:10436894
-
项目类别:
-
资助金额:$154.49万
-
财政年份:2021
-
负责人:DAVID EISENBERG
-
依托单位:
TRD1: Dedicated sample preparation for MicroED
-
批准号:10155527
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2020
-
负责人:DAVID EISENBERG
-
依托单位:
TRD1: Dedicated sample preparation for MicroED
-
批准号:10641815
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2020
-
负责人:DAVID EISENBERG
-
依托单位:
TRD1: Dedicated sample preparation for MicroED
-
批准号:10460922
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2020
-
负责人:DAVID EISENBERG
-
依托单位:
Structure and Inhibition of Amyloid in Alzheimer's Disease
-
批准号:9194224
-
项目类别:
-
资助金额:$377.99万
-
财政年份:2016
-
负责人:DAVID EISENBERG
-
依托单位:
Development of inhibitors for systemic amyloid diseases
-
批准号:9428606
-
项目类别:
-
资助金额:$10.78万
-
财政年份:2014
-
负责人:DAVID EISENBERG
-
依托单位:
Development of inhibitors for systemic amyloid diseases
-
批准号:9334041
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2014
-
负责人:DAVID EISENBERG
-
依托单位:
Development of inhibitors for systemic amyloid diseases
-
批准号:8752398
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2014
-
负责人:DAVID EISENBERG
-
依托单位:
Development of inhibitors for systemic amyloid diseases
-
批准号:8916013
-
项目类别:
-
资助金额:$30.62万
-
财政年份:2014
-
负责人:DAVID EISENBERG
-
依托单位:
PRION PROTEIN (PRP) SEGMENTS AND PRION DISEASE
-
批准号:8361684
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2011
-
负责人:DAVID EISENBERG
-
依托单位:
MYCOBACTERIUM TUBERCULOSIS RV3019C-RV3020C ESX COMPLEX
-
批准号:8361683
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2011
-
负责人:DAVID EISENBERG
-
依托单位:
TRUNCATED ALPHAA AND ALPHAB CRYSTALLINS
-
批准号:8361687
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2011
-
负责人:DAVID EISENBERG
-
依托单位:
?2-MICROGLOBULIN
-
批准号:8361688
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2011
-
负责人:DAVID EISENBERG
-
依托单位:
MOLECULAR MECHANISMS FOR PROTEIN-ENCODED INHERITANCE
-
批准号:8169290
-
项目类别:
-
资助金额:$2.48万
-
财政年份:2010
-
负责人:DAVID EISENBERG
-
依托单位:
STRUCTURE/ACTIVITY OF A MEMBER OF THE VAPBC FAMILY OF TOXIN ANTITOXIN SYSTEMS
-
批准号:8169257
-
项目类别:
-
资助金额:$2.48万
-
财政年份:2010
-
负责人:DAVID EISENBERG
-
依托单位:
MOLECULAR BASIS FOR INSULIN FIBRIL ASSEMBLY
-
批准号:8169254
-
项目类别:
-
资助金额:$2.48万
-
财政年份:2010
-
负责人:DAVID EISENBERG
-
依托单位: